Literature DB >> 22392913

Improved efficacy of dendritic cell-based immunotherapy by cutaneous laser illumination.

Xinyuan Chen1, Qiyan Zeng, Mei X Wu.   

Abstract

PURPOSE: The present study investigates a convenient laser-based approach to enhance dendritic cell (DC) migration and improve DC-based immunotherapy in murine models. EXPERIMENTAL
DESIGN: Influence of laser illumination on dermal tissue microenvironment and migration of DCs following intradermal injection were determined by whole-mount immunohistochemistry, transmission electron microscope, and flow cytometry. We also investigated in vivo expansion of CTLs by flow cytometry, CTL activity by in vitro CTL assay, and antitumor efficacy of DC immunization following cutaneous laser illumination in both preventive and therapeutic tumor models.
RESULTS: Laser illumination was found to significantly enlarge perforations in the perilymphatic basement membrane, disarray collagen fibers, and disrupt cell-matrix interactions in the dermis. The altered dermal tissue microenvironment permitted more efficient migration of intradermally injected DCs from the dermis to the draining lymph nodes (dLN). Laser illumination also slightly but significantly enhanced the expression of costimulatory molecule CD80 and MHC I on inoculated DCs. As a result, more vigorous expansion of tumor-specific IFN-γ(+)CD8(+) T lymphocytes and enhanced CTL activity against 4T1 but not irrelevant tumor cells were obtained in the laser-treated group over the control group. Laser-augmented DC immunization also completely abrogated early growth of 4T1 tumor and B16F10 melanoma in preventive tumor models and significantly extended the survival of 4T1-resected mice in a therapeutic tumor model.
CONCLUSION: These data suggest a simple, safe, laser-based approach to significantly enhance DC-based immunotherapy. ©2012 AACR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22392913      PMCID: PMC3328606          DOI: 10.1158/1078-0432.CCR-11-2654

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  35 in total

1.  Ultrastructural evidence of stratum corneum permeabilization induced by photomechanical waves.

Authors:  Gopinathan K Menon; Nikiforos Kollias; Apostolos G Doukas
Journal:  J Invest Dermatol       Date:  2003-07       Impact factor: 8.551

Review 2.  Dendritic cell immunotherapy: mapping the way.

Authors:  Carl G Figdor; I Jolanda M de Vries; W Joost Lesterhuis; Cornelis J M Melief
Journal:  Nat Med       Date:  2004-05       Impact factor: 53.440

3.  CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions.

Authors:  Lars Ohl; Mariette Mohaupt; Niklas Czeloth; Gabriele Hintzen; Ziba Kiafard; Jörg Zwirner; Thomas Blankenstein; Golo Henning; Reinhold Förster
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

Review 4.  Studying the mononuclear phagocyte system in the molecular age.

Authors:  Andrew Chow; Brian D Brown; Miriam Merad
Journal:  Nat Rev Immunol       Date:  2011-10-25       Impact factor: 53.106

5.  Dendritic cells injected via different routes induce immunity in cancer patients.

Authors:  L Fong; D Brockstedt; C Benike; L Wu; E G Engleman
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

6.  Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin.

Authors:  Gudrun Ratzinger; Patrizia Stoitzner; Susanne Ebner; Manfred B Lutz; Guy T Layton; Christian Rainer; Robert M Senior; J Michael Shipley; Peter Fritsch; Gerold Schuler; Nikolaus Romani
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

7.  T-cell engagement of dendritic cells rapidly rearranges MHC class II transport.

Authors:  Marianne Boes; Jan Cerny; Ramiro Massol; Marjolein Op den Brouw; Tom Kirchhausen; Jianzhu Chen; Hidde L Ploegh
Journal:  Nature       Date:  2002-08-29       Impact factor: 49.962

8.  CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, b cell outgrowth, and sustained neutrophilic inflammation.

Authors:  N Sato; S K Ahuja; M Quinones; V Kostecki; R L Reddick; P C Melby; W A Kuziel; S S Ahuja
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

9.  Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming.

Authors:  Alfonso MartIn-Fontecha; Silvia Sebastiani; Uta E Höpken; Mariagrazia Uguccioni; Martin Lipp; Antonio Lanzavecchia; Federica Sallusto
Journal:  J Exp Med       Date:  2003-08-18       Impact factor: 14.307

10.  Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control.

Authors:  David W Mullins; Stacey L Sheasley; Rebecca M Ream; Timothy N J Bullock; Yang-Xin Fu; Victor H Engelhard
Journal:  J Exp Med       Date:  2003-10-06       Impact factor: 14.307

View more
  18 in total

Review 1.  An update on the use of laser technology in skin vaccination.

Authors:  Xinyuan Chen; Ji Wang; Dilip Shah; Mei X Wu
Journal:  Expert Rev Vaccines       Date:  2013-10-16       Impact factor: 5.217

2.  Real-time imaging of dendritic cell responses to sterile tissue injury.

Authors:  Chi Ching Goh; Jackson LiangYao Li; Sapna Devi; Nadja Bakocevic; Peter See; Anis Larbi; Wolfgang Weninger; Florent Ginhoux; Veronique Angeli; Lai Guan Ng
Journal:  J Invest Dermatol       Date:  2014-11-28       Impact factor: 8.551

Review 3.  Laser vaccine adjuvants. History, progress, and potential.

Authors:  Satoshi Kashiwagi; Timothy Brauns; Jeffrey Gelfand; Mark C Poznansky
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

4.  Brief Exposure of Skin to Near-Infrared Laser Modulates Mast Cell Function and Augments the Immune Response.

Authors:  Yoshifumi Kimizuka; Wataru Katagiri; Joseph J Locascio; Ayako Shigeta; Yuri Sasaki; Mai Shibata; Kaitlyn Morse; Ruxandra F Sîrbulescu; Mizuki Miyatake; Patrick Reeves; Makoto Suematsu; Jeffrey Gelfand; Timothy Brauns; Mark C Poznansky; Kosuke Tsukada; Satoshi Kashiwagi
Journal:  J Immunol       Date:  2018-11-12       Impact factor: 5.422

5.  A New Era in Systemic Therapy for Hepatocellular Carcinoma: Atezolizumab plus Bevacizumab Combination Therapy.

Authors:  Masatoshi Kudo
Journal:  Liver Cancer       Date:  2020-03-05       Impact factor: 11.740

6.  Sustained epidermal powder drug delivery via skin microchannels.

Authors:  Yan Cao; Prateek Kakar; Md Nazir Hossen; Mei X Wu; Xinyuan Chen
Journal:  J Control Release       Date:  2017-01-27       Impact factor: 9.776

7.  Improving immunogenicity and safety of flagellin as vaccine carrier by high-density display on virus-like particle surface.

Authors:  Yiwen Zhao; Zhuofan Li; Xiaoyue Zhu; Yan Cao; Xinyuan Chen
Journal:  Biomaterials       Date:  2020-04-12       Impact factor: 12.479

8.  Laser adjuvant for vaccination.

Authors:  Satoshi Kashiwagi
Journal:  FASEB J       Date:  2020-01-28       Impact factor: 5.191

9.  Physical activation of innate immunity by spiky particles.

Authors:  Ji Wang; Hui-Jiuan Chen; Tian Hang; Yang Yu; Guishi Liu; Gen He; Shuai Xiao; Bo-Ru Yang; Chengduan Yang; Fanmao Liu; Jun Tao; Mei X Wu; Xi Xie
Journal:  Nat Nanotechnol       Date:  2018-10-29       Impact factor: 39.213

Review 10.  Laser microporation of the skin: prospects for painless application of protective and therapeutic vaccines.

Authors:  Sandra Scheiblhofer; Josef Thalhamer; Richard Weiss
Journal:  Expert Opin Drug Deliv       Date:  2013-02-21       Impact factor: 6.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.